(b)(6) clinical study.It was reported that a stent fracture occurred.The patient was enrolled in the (b)(6) study in (b)(6) 2016.The target lesion was located in the right leg mid superficial femoral artery (sfa) with 100% stenosis and was 40 mm long with a proximal reference vessel diameter of 6.00 mm and distal vessel diameter of 6.00 mm and was classified as tasc ii a lesion.Target lesion was treated with pre-dilatation and placement of a 7mm x 60mm study stent.Following post-dilatation, residual stenosis was 0%.(b)(6) 2017, 338 days after index procedure, during the 12 month follow up, x-ray was performed which revealed stent fracture in the study stent deployed in the right mid sfa.It was also noted that the patient had a pain-free 6 minute hall walk test.No patient complications were reported.This product is only ous approved but it is similar to an approved us device.
|